Fig. 3From: Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancerROC AUC for circN4BP2L2, CA125, HE4 and the combination (circN4BP2L2, CA125, and HE4) in epithelial ovarian cancer compared to those in benign (A) and normal (B) cohortsBack to article page